HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial.
about
Phlebotonics for venous insufficiencyRutosides for treatment of post-thrombotic syndromeRutosides for treatment of post-thrombotic syndromePhlebotonics for venous insufficiencyHR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study.HR, 0-(beta-hydroxyethyl)-rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study.Venoruton vs Daflon: evaluation of effects on quality of life in chronic venous insufficiency.A review of the microcirculation in skin in patients with chronic venous insufficiency: the problem and the evidence available for therapeutic options.Five-year treatment of chronic venous insufficiency with O-(β-hydroxyethyl)-rutosides: safety aspectsA systematic review of the efficacy and tolerability of hydroxyethylrutosides for improvement of the signs and symptoms of chronic venous insufficiency.Calcium dobesilate and oxerutin: effectiveness of combination therapy.HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in chronic venous disease and microangiopathy: an independent prospective, controlled, randomized trial.
P2860
Q24185918-338AB734-CC81-4720-8020-C66EB5D99A37Q24187159-C662D8CC-9B85-4592-830B-E3158987DAC0Q24197834-C5B7C124-635D-4011-AF4F-463EA695E453Q24246661-002C28B4-8435-4CE5-ACC5-C4809E796F44Q33211283-8A1DF278-695D-41F1-AE4B-011C1EEA6A8DQ33213288-73D69573-6EDD-403B-8744-EAC6C59C9B4DQ34565437-D320BEAE-9A5E-4975-B8C1-D776292B553FQ36575136-B7FB37E6-3D06-4076-B63C-4ADDCB89C7C6Q37307537-B9232AA3-64A7-4337-9A96-D978D69AC358Q38335665-13D0FFE2-5DBF-4E7A-88CD-E634E1E83E5BQ39288605-F52CEA7C-EBE5-402D-917D-A4EC5ECF66DCQ44136939-3FE4EAAA-FBEF-45FD-AFF3-F079B184BB29
P2860
HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
HR (Paroven, Venoruton; 0-(bet ...... -controlled, randomized trial.
@ast
HR (Paroven, Venoruton; 0-(bet ...... -controlled, randomized trial.
@en
HR (Paroven, Venoruton; 0-(bet ...... -controlled, randomized trial.
@nl
type
label
HR (Paroven, Venoruton; 0-(bet ...... -controlled, randomized trial.
@ast
HR (Paroven, Venoruton; 0-(bet ...... -controlled, randomized trial.
@en
HR (Paroven, Venoruton; 0-(bet ...... -controlled, randomized trial.
@nl
prefLabel
HR (Paroven, Venoruton; 0-(bet ...... -controlled, randomized trial.
@ast
HR (Paroven, Venoruton; 0-(bet ...... -controlled, randomized trial.
@en
HR (Paroven, Venoruton; 0-(bet ...... -controlled, randomized trial.
@nl
P2093
P1476
HR (Paroven, Venoruton; 0-(bet ...... -controlled, randomized trial.
@en
P2093
E Ippolito
G Geroulakos
L Incandela
M R Cesarone
P2860
P304
P356
10.1177/107424840200700103
P478
P577
2002-01-01T00:00:00Z